饮用水中的微量含量和痴呆风险:系统性审查
Julia Fraiha-Pegado1, Vanessa J Rodrigues de Paula2, Tariq Alotaibi1,3
1Department of Psychiatry, Dalhousie University, 909 Veteran's Memorial Lane, Halifax, Canada.
International journal of bipolar disorders
|August 30, 2024
概括
饮用水中的微量可能会降低痴呆风险和死亡率,即使是低剂量. 对低剂量用于痴呆症预防和治疗的进一步研究是有必要的.
科学领域:
- 神经科学是一个神经科学.
- 老年学是一门学科.
- 公共卫生 公共卫生
背景情况:
- 自1949年以来, (Li) 是一种主要的情绪稳定剂.
- 的神经保护性质在各种研究中得到了充分证实.
- 人们越来越有兴趣重新利用来进行神经保护,但最佳剂量仍然不清楚.
研究的目的:
- 审查有关饮用水中微量含量与痴呆症之间关系的现有数据.
- 挑战传统的高剂量模式对的治疗效果.
- 探索低剂量在预防认知衰退方面的潜力.
主要方法:
- 对五项研究的系统审查,这些研究检查了水中的微量和痴呆症发病率/死亡率.
- 分析报告的度及其与痴呆风险的相关性.
- 对对痴呆症的性别特异性影响的评估.
主要成果:
- 饮用水中微量含量低至0.002 mg/L,与降低痴呆风险或死亡率有关.
- 低于0.002 mg/L的含量没有显著影响.
- 虽然一些研究显示两性都有益处,但有一项研究仅在女性0.002 mg/L时发现效果.
结论:
- 有证据表明,水中的微量足以降低痴呆症发病率和死亡率.
- 这些发现强调了低剂量或微剂量在痴呆症预防和治疗方面的潜力.
- 进一步的临床试验应该调查痴呆症的长期低剂量干预措施.
相关概念视频
Mania and Antimanic Drugs: Overview
155
Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as...
155
Long-term Depression
2.5K
Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over...
Calcium Ion Concentration Mechanism
If over...
2.5K
Dementia
107
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
107
Alzheimer's Disease: Overview
454
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
454
Role of Neurotransmitters in Memory
485
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
485


